Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1976 Feb;13(1):1–8. doi: 10.1136/jmg.13.1.1

Aspects of pre-eclamptic toxaemia of pregnancy, consanguinity, twinning in Ankara.

A C Stevenson, B Say, S Ustaoglu, Z Durmus
PMCID: PMC1013340  PMID: 1271421

Abstract

It appears that women classed as having pre-eclamptic toxaemia are less frequently consanguineous with their husbands than all other mothers and in particular those mothers classed as having pregnancies complicated by chronic hypertensive disease. Search revealed no evidence for possible biases which could have stimulated such findings. Further evidence is advanced suggesting that, though pre-eclamptic toxaemia is more common in all types of twin pregnancies than in single births, it is more common where the twins are dizygous than where they are monozygous. It is pointed out that both these findings would be expected if there was a contribution to the aetiology of pre-eclamptic toxaemia by maternal/fetal immunological incompatibility. However, if such a mechanism exists it is not always determined at the same gene locus.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abul-Einen M., Toppozada H. K. Aspects of births in the Shatby Hospital, Alexandria. Br J Prev Soc Med. 1966 Oct;20(4):176–180. doi: 10.1136/jech.20.4.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BROWNE F. J., SHEUMACK D. R. Chronic hypertension following pre-eclamptic toxaemia; the influence of familial hypertension on its causation. J Obstet Gynaecol Br Emp. 1956 Oct;63(5):677–679. doi: 10.1111/j.1471-0528.1956.tb05545.x. [DOI] [PubMed] [Google Scholar]
  3. Chesley L. C., Annitto J. E., Cosgrove R. A. The familial factor in toxemia of pregnancy. Obstet Gynecol. 1968 Sep;32(3):303–311. [PubMed] [Google Scholar]
  4. Davies A. M., Czaczkes J. W., Sadovsky E., Prywes R., Weiskopf P., Sterk V. V. Toxemia of pregnancy in Jerusalem. I. Epidemiological studies of a total community. Isr J Med Sci. 1970 Mar-Apr;6(2):253–266. [PubMed] [Google Scholar]
  5. HAMILTON M., PICKERING G. W., ROBERTS J. A. F., SOWRY G. S. The aetiology of essential hypertension. I. The arterial pressure in the general population. Clin Sci. 1954 Feb;13(1):11–35. [PubMed] [Google Scholar]
  6. HULKA J. F., BRINTON V., SCHAAF J., BANEY C. Appearance of antibodies to trophoblast during the postpartum period in normal human pregnancies. Nature. 1963 May 4;198:501–502. doi: 10.1038/198501a0. [DOI] [PubMed] [Google Scholar]
  7. Jeffcoate T. N. Pre-eclampsia and eclampsia: the disease of theories. Proc R Soc Med. 1966 May;59(5):397–404. doi: 10.1177/003591576605900503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Loke Y. W., Joysey V. C., Borland R. HL-A antigens on human trophoblast cells. Nature. 1971 Aug 6;232(5310):403–405. doi: 10.1038/232403a0. [DOI] [PubMed] [Google Scholar]
  9. PAYNE R., ROLFS M. R. Fetomaternal leukocyte incompatibility. J Clin Invest. 1958 Dec;37(12):1756–1763. doi: 10.1172/JCI103768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Stevenson A. C., Davison B. C., Say B., Ustuoplu S., Liya D., Abul-Einen M., Toppozada H. K. Contribution of fetal/maternal incompatibility to aetiology of pre-eclamptic toxaemia. Lancet. 1971 Dec 11;2(7737):1286–1289. doi: 10.1016/s0140-6736(71)90604-0. [DOI] [PubMed] [Google Scholar]
  11. VAN ROOD J. J., EERNISSE J. G., VAN LEEUWEN A. Leucocyte antibodies in sera from pregnant women. Nature. 1958 Jun 21;181(4625):1735–1736. doi: 10.1038/1811735a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES